- Home
- WASH vs CTNM Comparison
WASH vs CTNM Comparison
Compare WASH & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | WASH | CTNM |
|---|---|---|
| Founded | 1800 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.2M | 575.3M |
| IPO Year | 1994 | 2024 |
Fundamental Metrics
Financial Performance| Metric | WASH | CTNM |
|---|---|---|
| Price | $34.39 | $14.73 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $31.25 | $18.60 |
| AVG Volume (30 Days) | 104.3K | ★ 175.3K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.51% | N/A |
| EPS Growth | ★ 266.26 | N/A |
| EPS | ★ 2.71 | N/A |
| Revenue | ★ $229,048,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.19 | N/A |
| P/E Ratio | $12.70 | ★ N/A |
| Revenue Growth | ★ 127.57 | N/A |
| 52 Week Low | $24.97 | $3.35 |
| 52 Week High | $37.08 | $16.33 |
Technical Indicators
Market Signals| Indicator | WASH | CTNM |
|---|---|---|
| Relative Strength Index (RSI) | 51.59 | 52.38 |
| Support Level | $26.60 | $13.86 |
| Resistance Level | $37.08 | $16.17 |
| Average True Range (ATR) | 1.24 | 0.91 |
| MACD | -0.34 | -0.22 |
| Stochastic Oscillator | 51.66 | 43.25 |
Price Performance
Historical ComparisonAbout WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
About CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.